News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SCOLR Pharma, Inc. (DDD) Announces Worldwide Licensing Agreement With Wyeth Consumer Healthcare (WYE)



12/22/2005 10:50:41 AM

BELLEVUE, Wash.--(BUSINESS WIRE)--Dec. 22, 2005--SCOLR Pharma, Inc. (Amex: DDD) announced today that it has executed a Licensing Agreement with Wyeth Consumer Healthcare, a division of Wyeth (NYSE: WYE), granting Wyeth Consumer Healthcare the worldwide rights to utilize SCOLR Pharma's proprietary and patented CDT(R) drug delivery platform for the potential use in an over-the-counter (OTC) formulation. There is currently no formulation of this type approved for use in North America.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES